Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (PACTR202609559057862) titled 'Comparison of Ziv-aflibercept and Ranibizumab for Macular Edema Secondary to Central Retinal Vein Occlusion' on Sept. 7.

Study Type: Interventional

Study Design: Parallel: different groups receive different interventions at same time during study,Randomised,Permuted block randomization,Central randomisation by phone/fax

Primary Sponsor: Ahmed Abdelrahman Mohamed Mohamed Saber

Condition: Eye Diseases Eye Diseases

Intervention: Intravitreal Ziv aflibercept

Recruitment Status: Not Recruiting

Phase: Not Applicable

Date of First Enrollment: 01/10/2024

Target Sample Size: 18

Countries of Recruitmen...